ASTERIAS BIOTHERAPEUTICS INC (AST) Stock Price, Quote, News and Overview
NYSEARCA:AST - NYSE Arca -
AST Quote, Performance and Key Statistics
0.945
-0.01 (-0.53%)
The current stock price of AST is 0.945 null. In the past month the price increased by 8.62%. In the past year, price decreased by -50.26%.
About AST
Company Profile
Asterias Biotherapeutics, Inc. is a biotechnology company. It is focused on the field of regenerative medicine. The Company's technologies center on stem cells capable of becoming all of the cell types in the human body, a property called pluripotency. It develops therapies based on pluripotent stem cells to treat diseases or injuries in a variety of medical fields, with an initial focus on the therapeutic areas of neurology and oncology. Asterias Biotherapeutics, Inc. is based in Menlo Park, California.
Company Info
ASTERIAS BIOTHERAPEUTICS INC
6300 DUMBARTON CIRCLE
FREMONT CA 94555
CEO: Michael H. Mulroy
Phone: 510-456-3800
ASTERIAS BIOTHERAPEUTICS INC / AST FAQ
What is the stock price of ASTERIAS BIOTHERAPEUTICS INC today?
The current stock price of AST is 0.945 null. The price decreased by -0.53% in the last trading session.
What is the ticker symbol for ASTERIAS BIOTHERAPEUTICS INC stock?
The exchange symbol of ASTERIAS BIOTHERAPEUTICS INC is AST and it is listed on the NYSE Arca exchange.
On which exchange is AST stock listed?
AST stock is listed on the NYSE Arca exchange.
What is ASTERIAS BIOTHERAPEUTICS INC worth?
ASTERIAS BIOTHERAPEUTICS INC (AST) has a market capitalization of 52.60M null. This makes AST a Micro Cap stock.
What are the support and resistance levels for ASTERIAS BIOTHERAPEUTICS INC (AST) stock?
ASTERIAS BIOTHERAPEUTICS INC (AST) has a support level at 0.89 and a resistance level at 0.95. Check the full technical report for a detailed analysis of AST support and resistance levels.
Should I buy ASTERIAS BIOTHERAPEUTICS INC (AST) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AST, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AST, evaluating the profitability, health, valuation and growth aspects
- ASTERIAS BIOTHERAPEUTICS INC (AST) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ASTERIAS BIOTHERAPEUTICS INC (AST) Sales and EPS estimates to see what analysts future expectations are.
- ASTERIAS BIOTHERAPEUTICS INC (AST) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ASTERIAS BIOTHERAPEUTICS INC (AST) Insider and Institutional Ownership to learn about the owners and their transactions.
- ASTERIAS BIOTHERAPEUTICS INC (AST) Stock Chart to make your own analysis
- ASTERIAS BIOTHERAPEUTICS INC (AST) Latest news and press-releases to stay up to date.
Does ASTERIAS BIOTHERAPEUTICS INC (AST) stock pay dividends?
AST does not pay a dividend.
What is the Price/Earnings (PE) ratio of ASTERIAS BIOTHERAPEUTICS INC (AST)?
ASTERIAS BIOTHERAPEUTICS INC (AST) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.39).
AST Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to AST. When comparing the yearly performance of all stocks, AST is a bad performer in the overall market: 92.87% of all stocks are doing better.
AST Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AST. AST may be in some trouble as it scores bad on both profitability and health.
AST Financial Highlights
Over the last trailing twelve months AST reported a non-GAAP Earnings per Share(EPS) of -0.39. The EPS increased by 42.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -2776.47% | ||
| ROA | -68.08% | ||
| ROE | -82.82% | ||
| Debt/Equity | 0 |